Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
JPMorgan Chase & Co reported a 5.10% stake in Rhythm Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Oct 13, 2026
JPMorgan Chase & Co reported a 5.10% stake in Rhythm Pharmaceuticals, Inc., 3,563,667 shares, as a passive investor on Sep 30, 2026. Filed Oct 13, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,563,667
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JPMORGAN CHASE & CO. | 5.10% | 3,563,667 |